New Market Study Published: Cytosystems Ltd - Product Pipeline Analysis
Cytosystems Ltd. (Cytosystem) develops advanced, laboratory-based diagnostic tests for cancer patients. It carries out diagnosis for bladder cancer and prostrate cance. The company has worldwide licence rights from Cancer Research Technology (CRT), the commercial arm of Cancer Research UK, for the deployment of MCM protein antibody diagnostics in bladder and prostate cancer. It has developed a urine-based screening and diagnostic solution for the detection of cancer of the bladder and the prostate including urine collection protocols, patented cell harvesting device,...
View full press release